Princeton, New Jersey, United States
3K followers 500+ connections

Join to view profile

About

Motivated and dedicated pharmaceutical professional accomplished in medical affairs…

Activity

Join now to see all activity

Experience & Education

  • Taiho Oncology

View Ning’s full experience

See their title, tenure and more.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Volunteer Experience

  • President (2014-2015)

    Sino-American Pharmaceutical Professionals Association

Publications

  • Development of highly potent inhibitors of Ras farnesyl transferase possessing cellular and in vivo activity.

    J. Med. Chem. 39 (1):224-236, 1996.

  • Farnesyltransferase inhibitors are inhibitors of ras, but not R-ras2/TC21, transformation.

    Oncogene, 10: 1905-1913, 1995.

  • Farnesyltransferase inhibitors block the NF 1 malignant phenotype.

    Cancer Research, 55:3569-3575, 1995.

  • Mechanisms and efficacy of heat and cold therapies for musculoskeletal injury.

    Postgrad Med. 127(1):57-65, 2015.

  • Nighttime and daytime atypical manifestations of gastroesophageal reflux disease: frequency, severity, and impact on health-related quality of life.

    Aliment Pharmacol Ther. 2008;27(4):327-337.

  • Pharmaceutical Regulation Goes Global: International Conference on Harmonization (Part I & II).

    Bio/Pharma Quarterly. 6(2): 3-6, 2000 and 6(3):18-23, 2000.

  • Ras farnesylation as a target for novel antitumor agents: potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase.

    Drug Dev. Res. 34:121-137, 1995.

  • RNAi Technologies: Accelerating Target Validation and Discovery.

    Acumen Sciences Strategic Advisory Report, 2002.

  • The Discovery and Structure-Activity Relationships of Imidazole-Containing Tetra-hydrobenzodiazepine Inhibitors of Farnesyltransferase.

    J. Med. Chem. 42(25):5241-5253, 1999.

  • The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity.

    Dig Dis Sci. 2010;55(4):952-9.

Join now to see all publications

More activity by Ning

View Ning’s full profile

  • See who you know in common
  • Get introduced
  • Contact Ning directly
Join to view full profile

Other similar profiles

Explore top content on LinkedIn

Find curated posts and insights for relevant topics all in one place.

View top content

Others named Ning Yan in United States